[Link] a note on oncogene.
An oncogene is a mutated or abnormally expressed form of a normal gene, called a proto-
oncogene, that has the ability to promote uncontrolled cell growth and lead to cancer. Proto-
oncogenes are normally involved in regulating cell division, growth, and differentiation, but
when they are altered, they become oncogenes and contribute to tumor formation.
Proto-oncogenes can be converted into oncogenes by various mechanisms such as point
mutations, gene amplification, chromosomal translocation, or insertion of viral genetic
material. These changes result in either increased production of growth-promoting proteins or
the formation of abnormal proteins that are continuously active.
Oncogenes usually act in a dominant manner, meaning that a mutation in a single allele is
sufficient to produce their effect. They lead to continuous stimulation of cell proliferation, even
in the absence of normal growth signals, resulting in uncontrolled cell division.
The proteins produced by oncogenes are involved in different steps of cell signaling pathways.
These include growth factors, growth factor receptors, signal transducers, transcription factors,
and cell cycle regulators. Due to their abnormal activity, these proteins drive excessive cell
growth and division.
Some well-known examples of oncogenes include RAS, which affects signal transduction; MYC,
which regulates gene transcription; and HER2/neu, which encodes a growth factor receptor.
Chromosomal translocation involving the ABL gene in chronic myeloid leukemia is another
important example.
Oncogenes play a crucial role in the development of cancer by promoting cell proliferation,
inhibiting apoptosis, and contributing to malignant transformation.
Thus, an oncogene is a cancer-causing gene formed from the mutation or abnormal activation
of a proto-oncogene, leading to uncontrolled cell growth and tumor development.
2. Describe the various types of cancer with suitable examples.
Cancer can be classified into different types based on the tissue or cell of origin. Each type has
distinct characteristics and examples.
Carcinomas are the most common type of cancers and arise from epithelial cells that line body
surfaces and cavities. These include cancers of the skin, lungs, breast, stomach, and colon.
Examples include breast carcinoma, lung carcinoma, and squamous cell carcinoma of the skin.
Sarcomas originate from connective tissues such as bone, cartilage, muscle, fat, and fibrous
tissue. They are relatively rare but often aggressive. Examples include osteosarcoma (bone
cancer), chondrosarcoma (cartilage cancer), and liposarcoma (fat tissue cancer).
Leukemias are cancers of blood-forming tissues, particularly the bone marrow, leading to the
production of abnormal white blood cells. These cells circulate in the blood instead of forming
solid tumors. Examples include acute lymphoblastic leukemia (ALL) and chronic myeloid
leukemia (CML).
Lymphomas are cancers that arise from lymphoid tissues such as lymph nodes, spleen, and
thymus. They affect the immune system. The two major types are Hodgkin lymphoma and Non-
Hodgkin lymphoma.
Myelomas are cancers of plasma cells, which are antibody-producing cells found in the bone
marrow. A common example is multiple myeloma, which leads to abnormal production of
immunoglobulins and bone damage.
Melanomas arise from melanocytes, the pigment-producing cells of the skin. These are highly
aggressive cancers and commonly occur due to excessive exposure to ultraviolet radiation. An
example is malignant melanoma of the skin.
Central nervous system cancers develop in the brain or spinal cord. These include tumors such
as gliomas and meningiomas. For example, glioblastoma is a highly malignant brain tumor.
Thus, cancers are broadly classified based on their tissue of origin into carcinomas, sarcomas,
leukemias, lymphomas, myelomas, melanomas, and central nervous system tumors, each with
specific features and examples.
3. What are oncogenic viruses? Write a note on DNA/ RNA viruses.
Oncogenic viruses are viruses that can cause cancer by altering the genetic material of host
cells. They introduce viral genes or affect normal cellular genes, leading to uncontrolled cell
division and malignant transformation. These viruses may activate proto-oncogenes or
inactivate tumor suppressor genes.
Oncogenic viruses are broadly classified into DNA viruses and RNA viruses:
DNA oncogenic viruses contain DNA as their genetic material and usually cause cancer by
integrating their DNA into the host cell genome or by producing proteins that interfere with
normal cell cycle regulation. These viral proteins can inactivate tumor suppressor proteins such
as p53 and Rb, leading to uncontrolled cell proliferation.
Examples include Human papillomavirus (HPV), which is associated with cervical cancer;
Epstein–Barr virus (EBV), linked to Burkitt lymphoma and nasopharyngeal carcinoma;
Hepatitis B virus (HBV), associated with liver cancer; and Adenovirus, which can induce tumors
in experimental animals. These viruses produce proteins that disrupt normal cell growth
control.
RNA oncogenic viruses usually belong to the group of retroviruses. They contain RNA as their
genetic material and use the enzyme reverse transcriptase to convert RNA into DNA, which then
integrates into the host genome. This integration can activate proto-oncogenes or introduce
viral oncogenes (v-onc).
Examples include Human T-cell leukemia virus type 1 (HTLV-1), which causes adult T-cell
leukemia, and Hepatitis C virus (HCV), which is associated with liver cancer. These viruses
promote continuous cell proliferation and inhibit normal cell death.
Thus, oncogenic viruses contribute to cancer development by altering genetic control
mechanisms of the host cell, and they are classified into DNA and RNA viruses based on their
genetic material and mode of action.
4. Explain in detail the process of cancer metastasis.
Cancer metastasis is the process by which cancer cells spread from the primary tumor to
distant organs and form secondary tumors. It is a complex, multistep process responsible for
the severity and fatality of most cancers.
Initially, cancer cells at the primary site undergo changes that reduce cell-to-cell adhesion. They
lose adhesion molecules such as cadherins, which normally keep cells attached to each other. As
a result, the cells become loosely connected and more mobile.
Next, the tumor cells invade the surrounding tissues. They secrete enzymes such as proteases
and matrix metalloproteinases (MMPs) that degrade the extracellular matrix and basement
membrane, allowing them to penetrate nearby structures.
After local invasion, the cancer cells enter the blood vessels or lymphatic vessels, a process
known as intravasation. This allows them to circulate throughout the body. While in circulation,
the tumor cells must survive immune attack and physical stress; many cells die, but some survive
by forming aggregates or binding with platelets.
The surviving cancer cells then reach distant organs and exit the blood or lymphatic vessels
through a process called extravasation. They adhere to the endothelial lining of capillaries and
migrate into the surrounding tissue.
Once in a new site, the cancer cells begin to grow and form secondary tumors. For successful
growth, they must adapt to the new environment and induce the formation of new blood vessels
through angiogenesis to supply nutrients and oxygen.
Metastasis commonly occurs in specific organs such as the lungs, liver, bones, and brain,
depending on the type of cancer. For example, breast cancer often spreads to bones and lungs,
while colon cancer commonly metastasizes to the liver.
Thus, cancer metastasis involves a series of steps including loss of adhesion, invasion,
intravasation, circulation, extravasation, and colonization, ultimately leading to the spread of
cancer to distant parts of the body.
5. Elaborate on the role of TP53, as a tumor suppressor gene.
TP53 is one of the most important tumor suppressor genes and is often called the “guardian of
the genome” because of its crucial role in maintaining genetic stability and preventing cancer
development. It encodes the p53 protein, a transcription factor that regulates the expression of
several genes involved in cell cycle control, DNA repair, and apoptosis.
Under normal conditions, p53 levels in the cell are low. However, in response to cellular stress
such as DNA damage, radiation, hypoxia, or oncogene activation, p53 becomes stabilized and
activated. Once activated, it binds to DNA and regulates the transcription of target genes.
One of the primary functions of p53 is to arrest the cell cycle, particularly at the G1/S checkpoint.
It does this by inducing the expression of p21, a cyclin-dependent kinase inhibitor. This prevents
the cell from progressing through the cell cycle, allowing time for DNA repair.
If the DNA damage is repairable, p53 activates genes involved in DNA repair mechanisms,
thereby restoring normal cell function. This prevents the propagation of mutations to daughter
cells.
If the damage is severe and cannot be repaired, p53 promotes apoptosis (programmed cell death)
by activating pro-apoptotic genes such as BAX and PUMA. This ensures that damaged or
abnormal cells are eliminated, preventing their transformation into cancer cells.
p53 also plays a role in senescence, a state of permanent cell cycle arrest, which further prevents
the proliferation of damaged cells.
Mutation or inactivation of the TP53 gene leads to loss of these protective functions. As a result,
cells with damaged DNA continue to divide, accumulate mutations, and may undergo malignant
transformation. TP53 mutations are found in a large number of human cancers.
Thus, TP53 acts as a critical tumor suppressor gene by regulating the cell cycle, promoting DNA
repair, inducing apoptosis, and maintaining genomic integrity, thereby preventing the
development of cancer.
6. Describe the role of retinoblastoma as a tumor suppressor protein.
The retinoblastoma protein (pRb), encoded by the RB1 gene, is a key tumor suppressor that
regulates the cell cycle and prevents uncontrolled cell proliferation. It plays a crucial role at the
G1/S checkpoint, thereby controlling the transition of cells from the G1 phase to the S phase.
In its active (hypophosphorylated) form, pRb binds to and inhibits transcription factors of the
E2F family. E2F proteins are required for the transcription of genes involved in DNA synthesis.
By binding to E2F, pRb prevents the expression of these genes and thus blocks progression into
the S phase, effectively stopping cell division.
When a cell receives proper growth signals, cyclin-dependent kinases (CDKs) phosphorylate
pRb. This phosphorylation inactivates pRb, causing it to release E2F transcription factors. Once
released, E2F activates genes necessary for DNA replication, allowing the cell to proceed into
the S phase. Thus, pRb acts as a molecular switch controlling cell cycle progression.
pRb also plays a role in maintaining cellular differentiation and genomic stability. It ensures that
cells only divide when conditions are appropriate and helps prevent the accumulation of genetic
damage.
When the RB1 gene is mutated or inactivated, pRb loses its ability to regulate E2F. As a result,
E2F remains continuously active, leading to uncontrolled cell division and tumor formation.
This is particularly seen in Retinoblastoma, a malignant tumor of the retina in children.
Mutations in RB1 are also associated with other cancers such as osteosarcoma.
The “two-hit hypothesis,” proposed by Alfred Knudson, explains that both alleles of the RB1 gene
must be inactivated for tumor development. This highlights its role as a tumor suppressor gene.
Thus, the retinoblastoma protein acts as a critical regulator of the cell cycle by controlling the
G1/S transition, inhibiting excessive cell proliferation, and maintaining normal cell growth,
thereby preventing cancer development.
7. Write the characteristics of an ideal tumor marker.
An ideal tumor marker should possess certain important characteristics to be clinically useful
in cancer diagnosis and management.
It should have high specificity, meaning it should be present only in cancer cells and not in
normal cells or benign conditions, so that false positive results are avoided.
It should have high sensitivity, so that even small amounts of tumor or early-stage cancers can
be detected accurately. The marker should be organ-specific or tumor-specific, helping to
identify the exact site or type of cancer.
Its levels should correlate with tumor burden, meaning the concentration of the marker should
increase with the size or extent of the tumor and decrease after [Link] should be useful for
early detection of cancer, ideally before clinical symptoms appear.
The marker should help in monitoring the response to therapy, showing a decline when
treatment is [Link] should be capable of detecting recurrence, rising again if the cancer
returns after treatment.
The test for the marker should be simple, rapid, and cost-effective, making it practical for
routine clinical use.
It should be reproducible and reliable, giving consistent results across different laboratories and
conditions. The marker should be easily measurable in accessible body fluids such as blood,
urine, or saliva, avoiding invasive procedures.
It should have a short half-life, so that changes in its levels can quickly reflect the current status
of the disease.
Finally, it should be clinically validated and widely accepted, with proven usefulness in
diagnosis, prognosis, and management of cancer.
8. Elaborate on the free radical theory of aging. with example
The free radical theory of aging states that aging occurs due to the accumulation of damage
caused by free radicals in cells over time. This theory was proposed by Denham Harman.
Free radicals are highly reactive molecules that contain an unpaired electron. Common
examples include reactive oxygen species (ROS) such as superoxide (O₂⁻), hydroxyl radical
(OH•), and hydrogen peroxide (H₂O₂). These are produced normally during metabolic
processes, especially during oxidative phosphorylation in mitochondria.
Because of their unstable nature, free radicals react with important cellular components such as
lipids, proteins, and DNA. This leads to structural and functional damage in cells.
One major effect is lipid peroxidation, where free radicals attack membrane lipids, causing
damage to cell membranes and affecting their permeability and integrity.
Free radicals also cause protein oxidation, leading to denaturation or loss of enzyme activity,
which disrupts normal cellular metabolism.
Damage to DNA is another critical effect, resulting in mutations, impaired replication, and
increased risk of cancer and cellular aging.
Over time, the body’s antioxidant defense systems (such as vitamin C, vitamin E, glutathione,
and enzymes like superoxide dismutase and catalase) become less effective, leading to increased
accumulation of oxidative damage.
This cumulative damage contributes to aging changes such as reduced cellular function, tissue
degeneration, and increased susceptibility to diseases like cancer, cardiovascular diseases, and
neurodegenerative disorders.
Example: When iron is exposed to air and moisture, it undergoes oxidation and forms rust.
Similarly, in the body, free radicals cause “oxidative damage” to cells over time, leading to aging.
Another simple example is skin aging. Continuous exposure to sunlight produces free radicals
in the skin, which damage skin cells, leading to wrinkles and loss of elasticity.
Thus, aging can be explained as the gradual accumulation of damage caused by free radicals in
the body.
9. Elaborate on the glycation theory of aging.
The glycation theory of aging explains that aging occurs due to the gradual accumulation of
damage caused by non-enzymatic reactions between sugars and biomolecules such as
proteins, lipids, and nucleic acids.
Glycation is a chemical process in which reducing sugars like glucose react with amino groups
of proteins without the help of enzymes. Initially, this forms unstable compounds called Schiff
bases, which rearrange into more stable Amadori products. Over time, these products undergo
further complex reactions to form advanced glycation end products (AGEs).
AGEs accumulate in various tissues of the body and cause structural and functional damage.
They form cross-links between proteins, especially long-lived proteins like collagen and elastin.
This leads to loss of elasticity and stiffness of tissues.
In connective tissues such as skin, glycation causes collagen to become rigid, resulting in
wrinkles and reduced skin flexibility. In blood vessels, it leads to thickening and reduced
elasticity, contributing to vascular aging.
Glycation also affects enzyme activity by altering protein structure, thereby impairing normal
metabolic processes. It can damage nucleic acids and interfere with cellular repair mechanisms.
AGEs can bind to specific receptors (RAGE) on cell surfaces, triggering inflammation and
oxidative stress, which further accelerates cellular damage and aging.
This process is more rapid in conditions with high blood glucose levels, such as Diabetes
mellitus, where excessive glycation leads to complications like neuropathy, nephropathy, and
retinopathy.
Thus, the glycation theory of aging suggests that the accumulation of AGEs over time leads to
structural damage, loss of function, and increased susceptibility to age-related diseases,
contributing to the overall aging process.
10. Elaborate on the mitochondrial theory of aging.
The mitochondrial theory of aging states that aging occurs due to progressive damage to
mitochondria caused mainly by reactive oxygen species (ROS) generated during cellular
respiration.
Mitochondria are the sites of energy production (ATP synthesis) through oxidative
phosphorylation. During this process, small amounts of oxygen are incompletely reduced,
leading to the formation of free radicals such as superoxide and hydroxyl radicals.
These reactive oxygen species damage mitochondrial components, including mitochondrial
DNA (mtDNA), proteins, and lipids. Unlike nuclear DNA, mtDNA lacks protective histones and
has limited repair mechanisms, making it more susceptible to damage.
As damage accumulates, mitochondrial function declines, resulting in reduced ATP production.
This leads to decreased cellular energy supply, affecting normal cellular activities and
contributing to aging.
Damaged mitochondria also produce more free radicals, creating a vicious cycle of increasing
oxidative stress and further mitochondrial injury.
Over time, this results in cellular dysfunction, apoptosis (programmed cell death), and tissue
degeneration, which are characteristic features of aging.
This theory is supported by observations that increased oxidative damage and mitochondrial
dysfunction are associated with age-related diseases such as Parkinson’s disease and Alzheimer’s
disease.
Thus, the mitochondrial theory explains aging as a result of cumulative mitochondrial damage,
leading to reduced energy production, increased oxidative stress, and progressive decline in
cellular function.
11. How is telomere affected during the process of aging?
Telomeres are repetitive DNA sequences present at the ends of chromosomes that protect
them from damage and prevent loss of genetic material during cell division. They act like
protective caps, maintaining chromosomal stability.
During aging, telomeres gradually shorten with each cell division because DNA polymerase
cannot completely replicate the ends of linear DNA (end-replication problem). As a result, a
small portion of telomeric DNA is lost every time a cell divides.
Over time, this progressive shortening leads to critically short telomeres, at which point the cell
can no longer divide. This state is called replicative senescence, where cells remain metabolically
active but lose their ability to proliferate.
In some cases, very short telomeres can trigger apoptosis (programmed cell death) to prevent
genomic instability.
The enzyme telomerase can add telomeric repeats and maintain telomere length, but its activity
is low or absent in most somatic (body) cells. Therefore, telomere shortening continues as aging
progresses.
Shortened telomeres are associated with reduced tissue regeneration, impaired healing, and
overall decline in organ function. This contributes significantly to the aging process.
In contrast, many cancer cells show increased telomerase activity, which allows them to
maintain telomere length and divide indefinitely.
Thus, during aging, telomeres progressively shorten, leading to cellular senescence, reduced
regenerative capacity, and eventual tissue aging.
12. What are the morphological and cellular changes observed in a senescent cell?
Senescent cells show characteristic morphological and cellular changes as a result of aging and
loss of proliferative capacity.
Morphologically, senescent cells become enlarged and flattened compared to normal cells. They
often show an irregular shape with increased cell size and volume. The nucleus may also become
enlarged and sometimes irregular in outline.
There is an increase in cytoplasmic granularity, mainly due to the accumulation of lysosomes
and residual bodies. A typical feature is the presence of lipofuscin pigment, also called the “aging
pigment,” which accumulates as yellow-brown granules in the cytoplasm.
Senescent cells show reduced ability to divide, meaning they are in a state of permanent cell
cycle arrest (usually at the G1 phase). This is associated with increased expression of cell cycle
inhibitors such as p21 and p16.
At the cellular level, there is damage to DNA, including telomere shortening and accumulation
of mutations. This activates DNA damage response pathways.
Mitochondrial function is impaired, leading to reduced ATP production and increased
production of reactive oxygen species (ROS), which further damage cellular components.
There is also altered protein synthesis and degradation, resulting in accumulation of abnormal
or misfolded proteins within the cell.
Senescent cells exhibit a phenomenon known as senescence-associated secretory phenotype
(SASP), where they secrete inflammatory cytokines, growth factors, and proteases. This can
affect neighboring cells and promote tissue dysfunction.
Cell membrane changes occur, including altered permeability and receptor function, which
affect cell signaling.
Enzyme activity is often reduced, and metabolic processes become less efficient.
Overall, these changes lead to functional decline, reduced regenerative capacity, and contribute
to tissue aging and age-related diseases.
13. Explain with the help of a diagram intrinsic pathway of apoptosis.
The intrinsic pathway of apoptosis (mitochondrial pathway) is initiated by internal cellular
stress such as DNA damage, oxidative stress, or lack of growth factors. It is mainly regulated by
mitochondria and Bcl-2 family proteins.
When the cell experiences stress Cell stress (DNA damage, ROS, hypoxia)
(e.g., DNA damage), tumor ↓
suppressor proteins like p53 activate Activation of p53
pro-apoptotic proteins such as Bax, ↓
Bak, and PUMA. At the same time, Activation of Bax, Bak (Pro-apoptotic)
anti-apoptotic proteins like Bcl-2 Inhibition of Bcl-2 (Anti-apoptotic)
and Bcl-xL are inhibited. ↓
Mitochondrial outer membrane permeabilization
Activated Bax and Bak increase the
↓
permeability of the mitochondrial
Release of Cytochrome c
outer membrane (MOMP), leading
↓
to the formation of channels. This
Cytochrome c + Apaf-1 + ATP → Apoptosome
results in the release of cytochrome c
↓
and other pro-apoptotic factors (like Activation of Caspase-9
Smac/DIABLO, AIF) from the ↓
mitochondria into the cytosol. Activation of Caspase-3, Caspase-7
↓
Cytochrome c in the cytoplasm binds
DNA fragmentation & protein breakdown
with Apaf-1 (Apoptotic protease
↓
activating factor-1) and ATP, forming
APOPTOSIS
a complex called the apoptosome.
The apoptosome then recruits and activates procaspase-9, converting it into active caspase-9
(initiator caspase).
Caspase-9 further activates executioner caspases such as caspase-3 and caspase-7. These
enzymes degrade cellular proteins, fragment DNA, and destroy structural components of the
cell.
As a result, the cell undergoes characteristic apoptotic changes such as cell shrinkage, chromatin
condensation, membrane blebbing, and formation of apoptotic bodies, which are later removed
by phagocytes.
Conclusion:
The intrinsic pathway of apoptosis is a mitochondria-mediated mechanism that eliminates
damaged or unwanted cells in a controlled manner, thereby maintaining normal cellular
homeostasis and preventing disease.
14. Explain with the help of a diagram extrinsic
pathway of apoptosis. Diagram (Flow chart):
The extrinsic pathway of apoptosis (death Death ligand (FasL / TNF-α)
receptor pathway) is initiated by external ↓
signals when specific ligands bind to death Binding to death receptor (Fas / TNFR)
receptors present on the cell surface. This ↓
pathway does not primarily involve Formation of DISC (with FADD)
mitochondria and is triggered by immune or ↓
regulatory signals. Whenextracellular death Activation of Procaspase-8 → Caspase-8
ligands such as Fas ligand (FasL) or tumor
↓
necrosis factor (TNF-α) bind to their
Activation of executioner caspases
respective death receptors (Fas receptor/CD95
(Caspase-3, 6, 7)
or TNF receptor) on the cell membrane,
↓
receptor activation occurs.
DNA fragmentation & protein breakdown
This binding leads to the formation of a protein ↓
complex called the DISC (Death-Inducing APOPTOSIS
Signaling Complex). The DISC includes adaptor proteins like FADD (Fas-associated death
domain) along with procaspase-8.
Within this complex, procaspase-8 is activated to caspase-8 (initiator caspase). Activated
caspase-8 then directly activates executioner caspases such as caspase-3, caspase-6, and
caspase-7.
These executioner caspases degrade cellular proteins, activate endonucleases (like CAD), and
lead to DNA fragmentation and breakdown of structural components. In some cells, caspase-8
can also activate the intrinsic pathway by cleaving Bid into tBid, which then acts on
mitochondria, thereby linking both pathways.
As a result, the cell undergoes apoptosis with features such as membrane blebbing, chromatin
condensation, and formation of apoptotic bodies.
Conclusion:
The extrinsic pathway of apoptosis is a receptor-mediated process that allows the body to
eliminate unwanted or harmful cells through external signaling, playing a crucial role in
immune defense and tissue homeostasis.
15. Explain the deacetylation reaction involving sirtuins.
Sirtuins are a family of NAD⁺-dependent deacetylase enzymes (class III histone deacetylases)
that play an important role in regulating gene expression, metabolism, stress response, and
aging.
The deacetylation reaction catalyzed by sirtuins involves the removal of an acetyl (–COCH₃)
group from acetylated lysine residues of proteins, especially histones and certain non-histone
proteins.
In this reaction, NAD⁺ (nicotinamide adenine dinucleotide) is an essential cofactor. The acetyl
group from the substrate is transferred to NAD⁺, resulting in the formation of three products:
deacetylated protein, nicotinamide, and O-acetyl-ADP-ribose.
The mechanism begins when the acetylated protein binds to the sirtuin enzyme along with
NAD⁺. The enzyme then cleaves NAD⁺ into nicotinamide and ADP-ribose. The acetyl group
from the protein is transferred to the ADP-ribose moiety, forming O-acetyl-ADP-ribose, and the
protein is left in a deacetylated state.
Deacetylation of histones leads to chromatin condensation and reduced gene expression, while
deacetylation of non-histone proteins (such as transcription factors) can alter their activity,
stability, and function.
Sirtuins are involved in important cellular processes such as DNA repair, apoptosis,
inflammation, and energy metabolism. Their activity is closely linked to the cellular energy
status because they depend on NAD⁺ levels.
For example, SIRT1 deacetylates proteins like p53 and FOXO transcription factors, thereby
influencing cell survival and stress resistance.
Thus, the sirtuin-mediated deacetylation reaction is a crucial biochemical process that regulates
protein function, gene expression, and plays a significant role in aging and longevity.
16. How are hormonal levels affected during aging?
Hormonal levels undergo significant changes during aging due to alterations in endocrine
gland function and regulatory mechanisms, leading to various physiological effects.
With advancing age, there is a general decline in anabolic hormones. Growth hormone (GH)
secretion decreases, resulting in reduced protein synthesis, muscle mass, and increased body
fat. This is often referred to as somatopause.
There is also a reduction in sex hormones. In females, estrogen levels fall sharply after
menopause, leading to symptoms such as hot flashes, osteoporosis, and increased
cardiovascular risk. In males, testosterone levels gradually decline (andropause), resulting in
reduced muscle mass, libido, and energy levels.
Insulin sensitivity decreases with age, which may lead to impaired glucose tolerance and
increased risk of Type 2 Diabetes.
The levels of thyroid hormones may show mild changes. Although total levels may remain
relatively stable, the metabolic rate often decreases, contributing to reduced energy
expenditure.
There is an increase in cortisol levels or altered cortisol rhythm, which may contribute to muscle
breakdown, weakened immune response, and increased stress effects.
Melatonin secretion declines with age, affecting sleep patterns and leading to disturbances such
as insomnia.
There is also a decrease in dehydroepiandrosterone (DHEA) levels, which is associated with
reduced immunity, muscle strength, and overall vitality.
The regulation of calcium metabolism is affected due to decreased parathyroid hormone and
vitamin D activity, contributing to bone loss and osteoporosis.
Additionally, hormonal feedback mechanisms become less efficient, leading to impaired
coordination between endocrine glands.
Thus, aging is associated with a general decline in hormone production and altered hormonal
balance, which contributes to many age-related physiological changes and disorders.
17. Enlist the biomarkers of aging.
Biomarkers of aging are measurable biological parameters that indicate the rate and extent of
the aging process in an individual.
Telomere length is an important biomarker, as progressive shortening of telomeres reflects
cellular aging and reduced replicative capacity.
Levels of oxidative stress markers such as reactive oxygen species and lipid peroxidation
products (e.g., malondialdehyde) indicate cumulative cellular damage over time.
Advanced glycation end products (AGEs) are biomarkers formed due to glycation of proteins
and increase with age.
DNA damage markers, including mutations and strand breaks, reflect genomic instability
associated with aging.
Changes in mitochondrial function, such as reduced ATP production and increased
mitochondrial DNA mutations, are important indicators of aging.
Inflammatory markers like C-reactive protein (CRP) and cytokines (IL-6, TNF-α) increase with
age, indicating chronic low-grade inflammation (inflammaging).
Hormonal levels, such as decreased growth hormone, estrogen, testosterone, and DHEA, serve
as biomarkers of aging.
Protein oxidation and accumulation of abnormal proteins reflect impaired protein turnover and
cellular damage.
Lipofuscin accumulation in cells acts as a marker of aging due to buildup of waste products.
Decline in immune function (immunosenescence), including reduced T-cell activity, is also a
biomarker of aging.
Changes in metabolic parameters, such as insulin resistance and altered lipid profile, are
associated with aging. Functional biomarkers like reduced physical performance, muscle mass,
and cognitive function also indicate biological aging.
Thus, biomarkers of aging include molecular, cellular, biochemical, and functional parameters
that collectively reflect the aging process.
18. Enlist the agents that can be used for delaying aging.
Agents that can be used for delaying aging mainly act by reducing oxidative stress, improving
metabolism, and protecting cellular components.
Antioxidants such as vitamin C, vitamin E, and beta-carotene help neutralize free radicals and
reduce oxidative damage to cells.
Compounds like glutathione and antioxidant enzymes (superoxide dismutase and catalase) also
protect against cellular damage.
Caloric restriction and compounds that mimic it, such as resveratrol, help in activating sirtuins
and improving longevity. Resveratrol is known to activate sirtuins and improve mitochondrial
function.
Hormonal supplements such as growth hormone, melatonin, and dehydroepiandrosterone
(DHEA) may help counteract age-related hormonal decline.
Metformin is used for improving insulin sensitivity and has been studied for its potential anti-
aging effects.
Rapamycin is known to inhibit mTOR pathway and may slow down cellular aging.
Coenzyme Q10 supports mitochondrial function and reduces oxidative stress.
Omega-3 fatty acids help reduce inflammation and support cardiovascular health.
Polyphenols and flavonoids found in fruits and vegetables act as natural antioxidants and
protect against aging.
Adequate intake of vitamins and minerals supports normal cellular metabolism and prevents
deficiency-related aging effects.
Lifestyle-related agents such as regular physical exercise and a balanced diet also play a major
role in delaying aging.
Thus, various antioxidants, metabolic regulators, hormones, and lifestyle interventions can act
as agents to delay the aging process.